—

Print
Save
Email this link

Share Link

Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:

https://erc.bioscientifica.com/search?access=all&pageSize=10&q=prostate+cancer&sort=relevance&t=ERC-Warburg100
The link was not copied. Your current browser may not support copying via this button.

Link copied successfully

Search Results

You are looking at 1 - 1 of 1 items for :

prostate cancer x

100 Years of the Warburg Effect and Endocrine Cancer x

Refine by access: All content x

Clear All

MicroRNAs as regulators of tumor metabolism

Francesca Ruggieri

Francesca Ruggieri Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria

Search for other papers by Francesca Ruggieri in
Google Scholar
PubMed

Katharina Jonas

Katharina Jonas Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria

Search for other papers by Katharina Jonas in
Google Scholar
PubMed

Manuela Ferracin

Manuela Ferracin Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy

Search for other papers by Manuela Ferracin in
Google Scholar
PubMed

Michael Dengler

Michael Dengler Division of Oncology, Medical University of Graz, Graz, Austria

Search for other papers by Michael Dengler in
Google Scholar
PubMed

Vanessa Jӓger

Vanessa Jӓger Division of Oncology, Medical University of Graz, Graz, Austria

Search for other papers by Vanessa Jӓger in
Google Scholar
PubMed

, and

Martin Pichler

Martin Pichler Division of Oncology, Medical University of Graz, Graz, Austria
Research Unit “Non-Coding RNAs and Genome Editing in Cancer”, Division of Oncology, Medical University of Graz, Graz, Austria
Department of Hematology and Oncology, Medical Faculty, University of Augsburg, Augsburg, Germany
Translational Oncology, University Hospital of Augsburg, Augsburg, Germany

Search for other papers by Martin Pichler in
Google Scholar
PubMed

downregulated in different cancers, including renal cell carcinoma (RCC), esophageal squamous cell carcinoma (ESCC), glioblastoma, breast, colon, bladder, and prostate cancer (PC) ( Zhang et al. 2012 ). GLUT1 is a direct target of miR-1291, and a significant